Mylan Gets Summary Judgment Against Sanofi Antitrust Claims In EpiPen MDL

Mealey's (January 6, 2021, 8:54 AM EST) -- KANSAS CITY, Kan. — The Kansas federal judge overseeing the EpiPen multidistrict litigation on Dec. 17 granted summary judgment against Sanofi-Aventis US LLC in its antitrust claim against EpiPen maker Mylan...

To view the full article, register now.